跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 7 条关于
“JonesTrading”
全部
7
临床试验
0
药物
0
机构
0
资讯
7
4个月前
Analysts Maintain Strong Buy Consensus on Cullinan Management (CGEM) with Significant Upside Potential
9个月前
Curis Secures $20.2 Million Funding to Advance Emavusertib Cancer Pipeline Following Positive AML Trial Results
2年前
Vor Biopharma Announces Positive Data and New CD45 ADC Program, Analysts See Significant Upside
去年
Rapport Therapeutics Gains Buy Recommendation Based on RAP Platform and RAP-219 Potential
去年
Sozinibercept Shows Promise in Wet AMD Treatment as Opthea's Pivotal Trials Progress
3个月前
Analysts Maintain Strong Buy Consensus on Eli Lilly Amid Conflicting Healthcare Sector Sentiments
去年
Femasys Raises $4.5 Million to Advance Women's Health Technologies Including FemBloc Birth Control